- Orchid Pharma has received final approval from USFDA for Rasagiline tablets.
- The company has got an approval for its ANDA (Abbreviated New Drug Application) for Rasagiline tablets 0.5 mg and 1 mg.
- This product is a FTE (first-to-file) application with a shared 180-day exclusivity for Orchid.
No comments:
Post a Comment